Archive
Here you can find the archive of all Press Releases prior to 2021
Filter by date:
Showing 974 press releases before 2021
-
ONGLYZA (Saxagliptin) Cardiovascular Profile Acceptable According to FDA Advisory Committee
-
AstraZeneca to Participate in Tentative FDA Psychopharmacologic Drugs Advisory Committee in 6月
-
AstraZeneca Issues 2008 Annual Report
-
FDA Approves Symbicort for Chronic Obstructive Pulmonary Disease
-
AstraZeneca Receives FDA Complete Response Letter On Seroquel XR For Generalised Anxiety Disorder
-
AstraZeneca PLC Board Change
-
AstraZeneca To Participate In Tentative FDA Psychopharmacologic Drugs Advisory Committee
-
AstraZeneca’s Partner, MAP Pharmaceuticals, Announces Phase III Study Of Unit Dose Budesonide In Children With Asthma Did Not Meet Primary Endpoints
-
AstraZeneca’s Partner, POZEN Informed By FDA That Gastric Ulcers Are Valid Primary Endpoint In PN 400 Trials
-
AstraZeneca PLC Fourth Quarter and Full Year Results 2008
Latest articles and press releases
All of our latest press releases and articles are available to explore
